15 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... Society of America #HFrEF ... HeartFailure #Management #CHF ... ACCAHA2017 #cardiology #treatment ... #algorithm #sCHF
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Diagnosis and Treatment ... Guidelines: • ACC ... patients with HFrEF ... iron #deficiency #CHF ... #HFrEF #heartfailure
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
) Treatment - GDMT ... recommended by the ACC ... /ambcarerx #CHF ... #HFrEF #Pharmacology ... #Management #Treatment
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
another option in HFrEF ... milrinone) for HFrEF ... Revascularization, treatment ... NSAlDs, ACE-inhibitors ... #Checklist #CHF
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
Heart Failure Pathophysiology ... functional ID) Treatment ... composite endpoint of all-cause ... iron #deficiency #CHF ... #HFrEF #heartfailure
Iron Deficiency in Congestive Heart Failure (CHF)

Iron deficiency (ID) in heart failure is a common comorbidity
Heart Failure (CHF ... depot iron] Treatment ... Heart #Failure #CHF ... #pharmacology # ... pathophysiology
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
Ejection Fraction (HFrEF ... *Chronic HFrEF may ... endomyocardial biopsy Pharmacology ... : • ACE Inhibitors ... management #cardiology #pharmacology
Myocarditis 

5 Principles of
Myocarditis:
1. Build clinical suspicion
2. Decide on EMBx
3. Manage acute cardiac injury
4. Manage chronic
Fulminant: - Acute HF ... , Cardiogenic shock ... Low voltage Treatment ... agent, steroids, AC
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Pathophysiology ... complete paralysis of all ... - NORMAL CSF ... Treatment: • Plasmapheresis ... diagnosis #management #treatment
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Incidence: common in APL ... Triggers: ATRA treatment ... Pathophysiology ... sepsis), PE, DAH, CHF ... Renal Failure Treatment